未找到相关数据
Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor GSK2118436 (GSK436)
被引：24
作者：
Nathanson, K. L.
Martin, A.
Letrero, R.
D'Andrea, K. P.
O'Day, S.
Infante, J. R.
Falchook, G. S.
Millward, M.
Curtis, C. M.
Ma, B.
Gagnon, R. C.
Lebowitz, P. F.
Long, G. V.
Kefford, R. F.
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] GlaxoSmithKline, Collegeville, PA USA
[3] Angeles Clin, Los Angeles, CA USA
[4] Res Inst, Los Angeles, CA USA
[5] Sarah Cannon Canc Ctr, Nashville, TN USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Sir Charles Gairdner Hosp, Perth, WA, Australia
[8] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[9] Univ Sydney, Westmead Inst Canc Res, Melanoma Inst Australia, Westmead Hosp, Sydney, NSW 2006, Australia
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.8501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8501
引用
收藏
页数：1
相关论文